Newsmaker: O’Sullivan on research recruitment ethics

September 25, 2012
Brian O'Sullivan, MD

In the Tuesday, Sept. 25, Boston Globe, Brian O'Sullivan, MD, professor of pediatrics and director of the UMMS Bioethics Core, commented on a controversial pitch for participation in a hepatitis C drug trial made by a Harvard Medical School scientist. Ethicists have criticized the way in which the researcher presented the idea of the trial to a group of Exeter Hospital patients who were exposed to the virus by a technician now under federal indictment.


Read the full story:

Ethics of hepatitis C drug pitch questioned

Related story on UMassMedNow:

Bioethics Core will lead educational and research efforts